Response to Sakura713 Nov 2021 13:57
A number of scientists such as biochemists, virologists, immunologists, pharmacogenetics and others contribute on this board. Anyone searching into the interferon study going back to the 1980's to the present day is aware that a critical element that has to be considered is not just route of entry of interferon, but equally important is the dosage given to a patient. If an overdose of beta Interferon 1 is given it will have minimal clinical efficacy as was observed in the 1980's, however at the correct dose as used in phase 2 clinical studies in 2020 against Covid-19 that a significant beneficial effect is observed. Over the decades the production of interferons has probably improved to remove impurities. Over recent years more research papers that have been listed by many contributors were showing that at the correct dose of the value of different interferon therapies. I therefore agree on your observation of data reported in the 1980's however it is not relevant to the Synairgen Covid-19 therapy product.
Regards Tony